Menu
Search
|

Menu

Close
X

Valeritas Holdings Inc VLRX.OQ (NASDAQ Stock Exchange Capital Market)

1.29 USD
+0.00 (+0.00%)
As of 9:30 AM EDT
chart
Previous Close 1.29
Open 1.29
Volume 2,930
3m Avg Volume 137,921
Today’s High 1.29
Today’s Low 1.29
52 Week High 6.79
52 Week Low 0.78
Shares Outstanding (mil) 24.86
Market Capitalization (mil) 37.78
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY18
13
FY17
20
FY16
20
FY15
18
EPS (USD)
FY18
-2.345
FY17
-12.609
FY16
-68.038
FY15
-95.615
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.14
Price to Sales (TTM)
vs sector
1.61
6.55
Price to Book (MRQ)
vs sector
13.38
4.00
Price to Cash Flow (TTM)
vs sector
--
21.51
Total Debt to Equity (MRQ)
vs sector
1,363.78
14.15
LT Debt to Equity (MRQ)
vs sector
1,360.58
11.31
Return on Investment (TTM)
vs sector
-102.04
12.83
Return on Equity (TTM)
vs sector
-462.94
14.95

EXECUTIVE LEADERSHIP

Peter Devlin
Independent Chairman of the Board, Since 2017
Salary: --
Bonus: --
John Timberlake
President, Chief Executive Officer, Director, Since 2016
Salary: $414,577.00
Bonus: --
Erick Lucera
Chief Financial Officer, Executive Vice President, Since 2016
Salary: $276,250.00
Bonus: --
Geoffrey Jenkins
Executive Vice President - Manufacturing, Operations and Research & Development, Since 2009
Salary: $242,287.00
Bonus: --
Mark Conley
Vice President, Corporate Controller, Treasurer, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

750 US Highway 202 Ste 600
BRIDGEWATER   NJ   08807-2597

Phone: +1908.9279920
Site:

Valeritas Holdings, Inc. is a commercial-stage medical technology company. The Company is focused on developing technologies for Type 2 diabetes. The Company's product, the V-Go Wearable Insulin Delivery Device (V-Go), is an insulin delivery device that helps patients with Type 2 diabetes requiring insulin to maintain their target blood glucose goals. V-Go is a disposable insulin delivery device that a patient adheres to his or her skin every 24 hours. V-Go enables patients to closely mimic the body's normal physiologic pattern of insulin delivery throughout the day and to manage their diabetes with insulin without the need to plan a daily routine around multiple daily injections. The Company has developed V-Go utilizing its h-Patch platform as a patient-focused solution to address insulin therapies. Its h-Patch platform facilitates the subcutaneous delivery of injectable medicines to patients across a range of therapeutic areas.

SPONSORED STORIES